Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 1/20 | 0.56 |
| ▸ | PRKCG | P05129 | 1/20 | 0.56 |
| ▸ | PRKCB | P05771 | 1/20 | 0.56 |
| ▸ | PRKCA | P17252 | 1/20 | 0.56 |
| ▸ | PRKCH | P24723 | 1/20 | 0.56 |
| ▸ | PRKCI | P41743 | 1/20 | 0.56 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.56 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.56 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.56 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.56 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.56 |
| ▸ | CD209 | Q9NNX6 | 3/20 | 0.51 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ABL1 | P00519 | 1/20 | 0.50 |
| ▸ | ALPL | P05186 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | ALPI | P09923 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16186721 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL8254322 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL18328428 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL1923753 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL14217500 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL2300084 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL13851827 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL3516599 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL12030336 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL5545675 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180080057-A1 | DIAGNOSIS OF BACTERIAL VAGINOSIS | LONDON HEALTH SCI CT RES INC | 2018-03-22 | — | — | US | claimed |
| WO-2016161525-A1 | DIAGNOSIS OF BACTERIAL VAGINOSIS | REID GREGOR (CA) | 2016-10-13 | — | — | WO | claimed |
| CN-114868954-A | Tobacco humectant and method for improving tobacco moistening feeling | 上海龙殷生物科技有限公司 | 2022-08-09 | — | — | CN | disclosed |
| US-10934573-B2 | Diagnosis of bacterial vaginosis | LONDON HEALTH SCIENCES CENTRE RESEARCH INC. (CA) | 2021-03-02 | — | — | US | disclosed |
| US-20180080057-A1 | DIAGNOSIS OF BACTERIAL VAGINOSIS | LONDON HEALTH SCI CT RES INC | 2018-03-22 | — | — | US | disclosed |
| EP-1652435-B1 | Use of red algae subjected to extreme temperature and light conditions. | EXSYMOL SA (MC) | 2017-06-14 | — | — | EP | disclosed |
| WO-2016161525-A1 | DIAGNOSIS OF BACTERIAL VAGINOSIS | REID GREGOR (CA) | 2016-10-13 | — | — | WO | disclosed |
| EP-1453844-B1 | USE OF GLYCOSIDES OF MONO- AND DIACYLGLYCEROL AS ANTI-INFLAMMATORY AGENTS | UNIV AARHUS (DK) | 2013-11-20 | — | — | EP | disclosed |
| US-7483812-B2 | Method for determining a linear relationship from measured data that can be stored electronically | UNIVERSITAT POTSDAM (DE) | 2009-01-27 | — | — | US | disclosed |
| US-7084122-B2 | Use of glycosides of mono- and diacyglycerol as anti-inflammatory agents | UNIVERSITY OF COPENHAGEN (DK) | 2006-08-01 | — | — | US | disclosed |
| EP-1652435-A1 | Use of red algae subjected to extreme temperature and light conditions. | EXSYMOL S.A.M. (MC) | 2006-05-03 | — | — | EP | disclosed |
| US-20060015307-A1 | Method for determining a linear relationship from measured data that can be stored electronically | UNIVERSITAT POTSDAM (DE) | 2006-01-19 | — | — | US | disclosed |
| US-20050049205-A1 | Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents | UNIVERSITY OF COPENHAGEN (DK) | 2005-03-03 | — | — | US | disclosed |
| EP-1453844-A2 | USE OF GLYCOSIDES OF MONO- AND DIACYLGLYCEROL AS ANTI-INFLAMMATORY AGENTS | Danmarks Jordbrugsforskning (DK) | 2004-09-08 | — | — | EP | disclosed |
| US-20030139350-A1 | Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents | UNIVERSITY OF COPENHAGEN (DK) | 2003-07-24 | — | — | US | disclosed |
| WO-2003043613-A2 | USE OF GLYCOSIDES OF MONO- AND DIACYLGLYCEROL AS ANTI-INFLAMMATORY AGENTS | DANMARKS JORDBRUGSFORSKNING (DK) | 2003-05-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050049205-A1 | Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents | DGKZ, DGKG, DAGLA | PRKD3 720/4885PRKCG 701/4885PRKCB 1476/4885 |
| US-20030139350-A1 | Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents | DGKZ, DGKG, DGKK | PRKD3 712/4885PRKCG 757/4885PRKCB 1639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.